Skip to main content
    B

    bioAffinity Technologies, Inc. (BIAF)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $2.00
    -0.20 (-9.09%)

    Market Cap: $4.00M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    bioAffinity Technologies, Inc. (BIAF) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to bioAffinity Technologies are iSpecimen (ISPC), MDxHealth SA (MDXH) and Bioatla (BCAB). By market cap, bioAffinity Technologies ranks 7th of the 13 companies on this page; MDxHealth SA (MDXH) is the largest at $13.75M.

    Peer Comparison

    BIAF's ROIC of -376.1% is below the peer median of -14.3%, and its revenue growth of -26.0% is below the median of -6.3%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    bioAffinity Technologies (BIAF)$4.00MN/A0.3x-278.9%-376.1%-26.0%0.00%
    iSpecimen Inc (ISPC)$1.66MN/A1.8x0.0%N/A-78.7%0.00%
    MDxHealth SA (MDXH)$13.75MN/AN/A-38.3%-40.5%-17.2%0.00%
    Bioatla Inc (BCAB)$2.89MN/AN/A0.0%N/A31.6%0.00%
    XWELL Inc. (XWEL)$5.62MN/A0.2x-82.9%N/A-7.1%0.00%
    Trinity Biotech plc (TRIB)$4.96MN/AN/A-85.4%-14.3%-5.5%0.00%
    PharmaCyte Biotech Inc (PMCB)$3.77MN/AN/A0.0%N/A0.0%0.00%
    Ernexa Therapeutics Inc. (ERNA)$2.84MN/AN/A0.0%N/A-94.1%0.00%
    Azitra Inc (AZTR)$3.69MN/AN/A0.0%N/A-100.0%0.00%
    Creative Medical Technology Holdings Inc (CELZ)$4.01MN/AN/A0.0%N/A0.0%0.00%
    XTL Biopharmaceuticals Ltd ADR (XTLB)$3.93MN/A4.0x0.0%N/A0.0%0.00%
    Senti Biosciences Inc (SNTI)$5.38MN/A57.2x0.0%1039.8%-100.0%0.00%
    Intelligent Bio Solutions Inc. (INBS)$5.84MN/A1.0x-269.3%N/A25.2%0.00%
    Peer median$3.97MN/A1.8x0.0%-14.3%-6.3%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to bioAffinity Technologies, ranked by how closely their business, size, sector and industry match. The largest group, 7 of the 12, is in Biotechnology; the other 5 span 2 industries.

    CompanyAboutPeers
    iSpecimen Inc (ISPC)Diagnostics & Research
    iSpecimen, Inc. provides technology that connects life science researchers in need of human biofluids...
    ISPC competitors
    MDxHealth SA (MDXH)Diagnostics & Research
    MDxHealth SA is a prominent biotechnology company focused on precision diagnostics that enhance cancer management, particularly in prostate and bladder cancers.
    MDXH competitors
    Bioatla Inc (BCAB)Biotechnology
    BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers.
    BCAB competitors
    XWELL Inc. (XWEL)Diagnostics & Research
    XWELL Inc., a health and wellness services company, provides spa services at airports. The company is headquartered in New York, New York.
    XWEL competitors
    Trinity Biotech plc (TRIB)Medical Devices
    Trinity Biotech plc acquires, develops, manufactures and markets medical diagnostic products for the clinical laboratory and point of care (POC) segments...
    TRIB competitors
    PharmaCyte Biotech Inc (PMCB)Biotechnology
    PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United...
    PMCB competitors
    Ernexa Therapeutics Inc. (ERNA)Biotechnology
    Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients.
    ERNA competitors
    Azitra Inc (AZTR)Biotechnology
    Azitra Inc, a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live...
    AZTR competitors
    Creative Medical Technology Holdings Inc (CELZ)Biotechnology
    Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics...
    CELZ competitors
    XTL Biopharmaceuticals Ltd ADR (XTLB)Biotechnology
    XTL Biopharmaceuticals Ltd., a biopharmaceutical company, is engaged in the acquisition and development of pharmaceutical products for the treatment...
    Senti Biosciences Inc (SNTI)Biotechnology
    Senti Biosciences Inc (SNTI) is a leading biotechnology firm specializing in synthetic biology...
    SNTI competitors
    Intelligent Bio Solutions Inc. (INBS)Medical Devices
    Intelligent Bio Solutions Inc. (INBS) is a pioneering biotechnology company focused on delivering cutting-edge diagnostic solutions and biomarker-driven...
    INBS competitors

    Frequently Asked Questions About BIAF

    Who are bioAffinity Technologies' main competitors?

    The companies most similar to bioAffinity Technologies include iSpecimen (ISPC), MDxHealth SA (MDXH), Bioatla (BCAB), XWELL (XWEL) and Trinity Biotech (TRIB), listed from the closest match.

    Who is bioAffinity Technologies' biggest competitor?

    MDxHealth SA (MDXH) is the largest of the similar companies at $13.75M; iSpecimen (ISPC) is the closest match by business profile, size, sector and industry.

    How does BIAF stock compare with its competitors?

    BIAF's P/S is 0.3x against a peer median of 1.8x; its net margin is -278.9% against a peer median of 0.0%.

    Which of bioAffinity Technologies' competitors pays a higher dividend?

    bioAffinity Technologies pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is bioAffinity Technologies bigger than its competitors?

    No. bioAffinity Technologies is 7th by market cap among the 13 companies on this page; the largest is MDxHealth SA (MDXH) at $13.75M.